Indication

Louse-borne typhus

Louse-borne typhus, also designated epidemic typhus, is an acute, severe systemic rickettsial infection caused by the obligate intracellular bacterium *Rickettsia prowazekii*. Read more about Louse-borne typhus

150 drugs 90 manufacturers

Advertisement

Drugs that treat it

Common Louse-borne typhus therapies.

Showing 100–108 of 150 drugs

Filter & compare in the drug finder →Opens the drug finder with Louse-borne typhus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Louse-borne typhus.

Louse-borne typhus, also designated epidemic typhus, is an acute, severe systemic rickettsial infection caused by the obligate intracellular bacterium *Rickettsia prowazekii*.

It primarily affects populations living in overcrowded, unhygienic environments—such as refugee camps, prisons, and regions experiencing war, famine, or extreme poverty—where transmission is facilitated by the human body louse (*Pediculus humanus corporis*).

Pathophysiologically, the bacteria target and multiply within vascular endothelial cells, producing a widespread systemic vasculitis and microvascular leakage.

Clinically, the disease presents with the abrupt onset of high fevers, severe headache, prominent myalgias, and chills, followed typically by a centrifugal maculopapular rash, with severe cases progressing to confusion, delirium, renal failure, or life-threatening multiorgan dysfunction.

Personalize your experience

Follow Louse-borne typhus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it